200 shares received a buy rating from a brokerage, and the target price of FishLeap Medical has increased by 56.27%.

Wind data shows that on August 25th, a total of 200 stocks received a buy rating from securities firms, with 34 of them announcing target prices. According to the highest target price, Yu Yue Medical, CRRC Corporation, and Juxin Technology rank at the top in terms of target percentage increase, with increases of 56.27%, 41.85%, and 41.85% respectively. In terms of rating adjustments, 196 stocks maintained their ratings, while 4 stocks received their first rating. Additionally, 28 stocks were of interest to multiple securities firms, with Yu Yue Medical, Hualu Hengsheng, and Shanghai Electric Power ranking the highest in terms of the number of ratings received, with 4 firms, 3 firms, and 3 firms respectively giving ratings. In terms of the Wind industry to which the stocks receiving buy ratings belong, the Materials II, Capital Goods, and Semiconductor & Semiconductor Equipment industries have the highest number of buy-rated stocks, with 37, 34, and 22 stocks respectively.